CaloCurb
Calocurb® CLINICAL Starter Pack
Calocurb® CLINICAL STARTER PACK is a 125mg practitioner-exclusive supplement that supports appetite control by working with the body’s natural hormonal signals. It features Amarasate®, a clinically studied extract of New Zealand bitter hops, delivered in a delayed-release capsule designed to reach the small intestine where it activates bitter taste receptors. This triggers the release of key satiety hormones including GLP-1, CCK and PYY, which work together to significantly reduce hunger, cravings, and caloric intake. Fast-acting and plant-based, Calocurb® offers a targeted, science-driven approach to supporting healthy weight management.
Clinical Applications
- Reduces Appetite and Food Cravings
- Supports Long-Term Weight Management
- Stimulates Natural GLP-1, CCK and PYY Release
- Complements Lifestyle and Pharmaceutical Weight Loss Strategies
- Enhances Adherence to Intermittent Fasting and Time-Restricted Eating
Side Effects
Taking CaloCurb® for the first time may cause a mild laxative effect that should subside after 24 to 72 hours of use. This effect is due to the presence and activity of the cells responding to the Amarasate. Therefore, it’s recommended to gradually increase the dosage over five days.
Who Should NOT take CaloCurb
Calocurb® should not be taken by individuals that have any form of gastrointestinal inflammation or inflammatory bowel disease, such as Crohn’s or ulcerative colitis. Calocurb® is not indicated for patients with type 1 diabetes mellitus.
Calocurb® contains only three ingredients:
- Amarasate® A specific variety of New Zealand hops (Humulus Lupulus), GRAS approved, prepared using freshly picked hops and extracted by CO2 supercritical extraction.
- Inert Vegetable oil – GMO and pesticide-free
- Rosemary extract – a natural preservative.
***This product does NOT contain any wheat, gluten, dairy, lactose, egg, yeast, soy, artificial colours, artificial sweeteners, or artificial flavours.***
Evidence of Efficacy:
- Calocurb CLINICAL™ is supported by substantial research and human clinical trials, showing it significantly reduces hunger and food cravings while helping control caloric intake. The supplement’s active ingredient, Amarasate, has been demonstrated to decrease hunger by up to 30%, reduce cravings by up to 40%, and lower calorie consumption by an average of 18%. Additionally, it powerfully boosts satiety hormones, elevating GLP-1 and CCK to levels much higher than normal, which further supports appetite control and portion management.
Calocurb® CLINICAL MAINTENANCE
Calocurb® CLINICAL MAINTENANCE
Clinical Applications
- Reduces Appetite and Food Cravings
- Supports Long-Term Weight Management
- Stimulates Natural GLP-1, CCK and PYY Release
- Complements Lifestyle and Pharmaceutical Weight Loss Strategies
- Enhances Adherence to Intermittent Fasting and Time-Restricted Eating
Side Effects
Taking CaloCurb® for the first time may cause a mild laxative effect that should subside after 24 to 72 hours of use. This effect is due to the presence and activity of the cells responding to the Amarasate. Therefore, it’s recommended to gradually increase the dosage over five days.
Who Should NOT take CaloCurb
Calocurb® should not be taken by individuals that have any form of gastrointestinal inflammation or inflammatory bowel disease, such as Crohn’s or ulcerative colitis. Calocurb® is not indicated for patients with type 1 diabetes mellitus.
Calocurb® contains only three ingredients:
- Amarasate® A specific variety of New Zealand hops (Humulus Lupulus), GRAS approved, prepared using freshly picked hops and extracted by CO2 supercritical extraction.
- Inert Vegetable oil – GMO and pesticide-free
- Rosemary extract – a natural preservative.
***This product does NOT contain any wheat, gluten, dairy, lactose, egg, yeast, soy, artificial colours, artificial sweeteners, or artificial flavours.***
Evidence of Efficacy:
- Calocurb CLINICAL™ is supported by substantial research and human clinical trials, showing it significantly reduces hunger and food cravings while helping control caloric intake. The supplement’s active ingredient, Amarasate, has been demonstrated to decrease hunger by up to 30%, reduce cravings by up to 40%, and lower calorie consumption by an average of 18%. Additionally, it powerfully boosts satiety hormones, elevating GLP-1 and CCK to levels much higher than normal, which further supports appetite control and portion management.